Aims: To report clinical outcomes of a large series of cases with advanced thyroid cancer.
Study design: Three hundred and eighty-five patients at the UICC stages III and IV were selected for the study with thyroid cancer.
Results: Papillary carcinoma and sclerosing carcinoma have better survival than the Hürthle cell and insular types. Lymphatic metastasis does not appear to worsen the prognosis. All the tumour forms offer the chance of long survival.
Conclusions: Surgical treatment is the primary treatment of thyroid carcinoma. The combined treatments of surgery, metabolic beam therapy, suppressive hormone therapy, radiotherapy and chemotherapy cure a high percentage of patients with the tumour at an advanced stage.